Tacrolimus prolonged release
Sponsors
Astellas Pharma Europe Ltd.
Conditions
Heart TransplantationIntestine TransplantationKidney TransplantationLiver TransplantationLung Transplantation
Phase 2
Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®
CompletedNCT01294020
Start: 2011-05-25End: 2025-11-03Updated: 2026-07-07
A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time
CompletedNCT01614665
Start: 2012-04-03End: 2021-04-21Updated: 2024-11-01